Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isturisa in Management of Mild Autonomous Cortisol Secretion (MACS)
NCT07247058Phase 4Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Feb 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of osilodrostat in Autonomous Cortisol Secretion (ACS), sponsored by Johns Hopkins University. Started Feb 2026; status: recruiting.
02
Drugs
osilodrostat
03
Conditions
Autonomous Cortisol Secretion (ACS)
Beyond the preview
Go deeper on NCT07247058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247058.